anemodeanin a has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, XW; Kang, JY; Wang, FJ; Zhao, J | 1 |
| Deng, H; Dong, J; Kuang, Z; Liu, L; Liu, X; Liu, Z; Sun, C; Xiao, D; Yin, M; Zhang, N; Zhou, X | 1 |
2 other study(ies) available for anemodeanin a and Neoplasms
| Article | Year |
|---|---|
Raddeanin A synergistically enhances the anti-tumor effect of MAP30 in multiple ways, more than promoting endosomal escape.
Topics: Endosomes; Humans; Neoplasms; Ribosome Inactivating Proteins, Type 2; Saponins; Triterpenes | 2022 |
Raddeanin A Enhances Mitochondrial DNA-cGAS/STING Axis-Mediated Antitumor Immunity by Targeting Transactive Responsive DNA-Binding Protein 43.
Topics: Animals; DNA-Binding Proteins; DNA, Mitochondrial; Mitochondria; Neoplasms; Nucleotidyltransferases; Tumor Microenvironment | 2023 |